Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

Share Price is delayed by 15 minutes
Get Live Data
94.90    0.40 (0.42%)
Bid:
94.20
Ask:
94.50
Spread: 0.30 (0.318%)
Market Cap: £349.55m
CCR Live PriceLast checked at - London Stock Exchange

Intraday C&C Group Share Chart

FY2025 First-Half Trading Update

9 Sep 2024 07:00

RNS Number : 3304D
C&C Group Plc
09 September 2024
 

FY2025 First-Half Trading Update

 

Earnings in line with expectations; underlying Operating Profit of €39m-€41m, Core Revenues in line

 

Dublin, London, 9 September 2024: C&C Group plc ('C&C' or the 'Group') announces that earnings in the first half of the financial year to 31 August 2024 have been in line with expectations, with Net Revenues expected to be -3%1, reflecting growth in Matthew Clark & Bibendum, in-line performance across our core and premium brands, offset by the impact from the disposal of our NAB business in Ireland, lower contract brewing volumes and softer cider volumes in GB. Underlying Operating Profit is expected in the range of €39m-€41m, in line with our expectations, principally reflecting the phased rebuilding of our Distribution business profitability following last year's ERP disruption.

 

Tennent's achieved volume and value share growth over the latest 12-weeks2, supported by targeted marketing campaigns around the Euro 2024 tournament and, despite mixed summer weather, Bulmers outperformed the cider market in Ireland3. Our Premium beer and cider brands, driven by Menabrea and Orchard Pig, continued to perform strongly, reporting double digit revenue growth.

 

Performance in our Matthew Clark and Bibendum business has also been encouraging with Net Revenues expected to be +2%. Recovery from lost distribution customers in FY2024 has been strong, with distribution points for Matthew Clark and Bibendum in August +10% compared to August 2023. This growth, together with the efficiency initiatives implemented in the year to date, is expected to result in improved distribution margins in H1 FY2025.

 

Distribution Agreement with Budweiser Brewing Group

 

C&C and Budweiser Brewing Group ('BBG'), part of AB InBev, have mutually agreed to restructure elements of our trading relationship. Effective from 1st January 2025, C&C will reassume control and distribution of the Group's cider portfolio, including Magners, in Great Britain. On the same date, AB InBev will assume control and distribution of its beer portfolio in the Off Trade in the Republic of Ireland. Bringing the sales, trade marketing and distribution responsibilities in house will provide both companies with the opportunity to strengthen their respective brand portfolios and distribution platforms.

 

Outlook and Capital Returns

 

While current market conditions remain challenging, improving efficiencies, business simplification, winning customers and brand distribution remain our top priorities. We remain confident on achieving our operating profit target for the current financial year and making progress towards the operating profit target of €100m by FY2027.

 

The Board reaffirms its intention to distribute at least €150million to shareholders over three years while maintaining the Group's financial leverage target of approximately 1x EBITDA on a pre-IFRS16 basis. The second €15m tranche of our share buyback programme will commence today, 9 September 2024.

 

Board and CEO Appointment Process

 

Since the Annual General Meeting on 15 August 2024, we have been pleased to welcome Feargal O'Rourke as Non-Executive Director of the Board. Prior to retirement Feargal was Managing Partner of PwC Ireland and brings his considerable financial expertise to C&C. As previously announced, we intend to make a further non-executive appointment to the Board in the near future. We have also commenced the recruitment process for the new Chief Executive Officer with the support of executive search firm Russell Reynolds Associates. A progress update on these appointments will be provided in due course.

 

1 On a constant currency basis

2 On-Trade - CGA OPM (BWS) 52 w/e 13/7/2024, Off-Trade - IRI (Circana) Total GB 52 w/e 13/7/2024.

CGA 13 w/e to 30.06.24 - Ireland Total Cider

 

 

ENDS

Contacts

 

C&C Group plc

Email: investor.relations@candcgroup.ie

 

Investors, Analysts & Media

 

FTI Consulting

Jonathan Neilan / Paddy Berkery / Niamh O'Brien

Tel: +353 86 231 4135 / +353 86 6025988 / +353 87 707 8379

Email: CandCGroup@fticonsulting.com

 

 

About C&C Group plc

 

C&C Group plc is a leading, vertically integrated premium drinks company which manufactures, markets and distributes branded beer, cider, wine, spirits, and soft drinks across the UK and Ireland.

 

· C&C Group's portfolio of owned/exclusive brands include Bulmers, the leading Irish cider brand and Tennent's, the leading Scottish beer brand; as well as a range of fast-growing, premium and craft ciders and beers, such as Heverlee, Menabrea, Five Lamps and Orchard Pig. C&C exports its Magners and Tennent's brands to over 40 countries worldwide.

· C&C Group has owned brand and contract manufacturing/packing operations in Co.Tipperary, Ireland and Glasgow, Scotland.

· C&C is the No.1 drinks distributor to the UK and Ireland hospitality sectors. Operating through the Matthew Clark, Bibendum, Tennent's and Bulmers Ireland brands, the Group has a market leading range, scale and reach including an intimate understanding of the markets it serves. Together this provides a key route-to-market for major international beverage companies.

 

C&C Group plc is an Irish incorporated FTSE 250 company headquartered in Dublin and is listed on the London Stock Exchange.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBVLLBZKLBBBD
Date   Source Headline
15th Feb 20247:00 amRNSDirectorate Changes
2nd Feb 202410:00 amRNSTotal Voting Rights and Capital
15th Jan 20242:20 pmRNSDirector/PDMR Shareholding
4th Jan 202412:45 pmRNSTotal Voting Rights
18th Dec 20233:30 pmRNSDirector/PDMR Shareholding
12th Dec 20231:05 pmRNSHolding(s) in Company
6th Dec 20233:30 pmRNSDirectorate Change
5th Dec 20232:10 pmRNSBlock listing Interim Review
4th Dec 202311:15 amRNSTotal Voting Rights and Capital
16th Nov 20236:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20232:56 pmRNSHolding(s) in Company
2nd Nov 202312:44 pmRNSDirector/PDMR Shareholding
31st Oct 20233:00 pmRNSTotal Voting Rights
30th Oct 20233:45 pmRNSDirector/PDMR Shareholding
26th Oct 20237:00 amBUSHalf-year Report
16th Oct 20235:16 pmRNSDirector/PDMR Shareholding
6th Oct 202312:30 pmRNSHolding(s) in Company
27th Sep 20233:56 pmRNSHolding(s) in Company
19th Sep 20237:00 amBUSStatement re FY2024 H1 pre-close Trading Statement
15th Sep 20232:10 pmRNSDirector/PDMR Shareholding
31st Aug 20237:00 amRNSDirectorate Changes
18th Aug 20239:35 amRNSDirector Declaration
16th Aug 20234:15 pmRNSDirector/PDMR Shareholding
20th Jul 20239:00 amRNSDirector Declaration
17th Jul 20233:15 pmRNSDirector/PDMR Shareholding
13th Jul 20231:00 pmRNSResult of AGM
13th Jul 20237:00 amBUSAGM Statement
6th Jul 20234:00 pmRNSHolding(s) in Company
3rd Jul 20235:45 pmRNSHolding(s) in Company
26th Jun 202312:06 pmRNSHolding(s) in Company
16th Jun 20232:00 pmRNSDirector/PDMR Shareholding
14th Jun 20236:05 pmRNSDirector/PDMR Shareholding
14th Jun 20238:30 amRNSAnnual Report & Notice of AGM
13th Jun 20234:30 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSBlock listing Interim Review
30th May 20237:00 amRNSHolding(s) in Company
26th May 202312:15 pmRNSDirector/PDMR Shareholding
24th May 20231:45 pmRNSDirector/PDMR Shareholding
24th May 202312:00 pmRNSDirector/PDMR Shareholding
24th May 20237:00 amBUSFinal Results
19th May 20237:00 amBUSStatement re Trading Update & Directorate Changes
16th May 20232:00 pmRNSDirector/PDMR Shareholding
4th May 20231:30 pmRNSHolding(s) in Company
17th Apr 20233:45 pmRNSDirector/PDMR Shareholding
23rd Mar 20237:00 amBUSPre-close Trading Statement
16th Mar 20233:15 pmRNSDirector/PDMR Shareholding
15th Mar 20232:00 pmRNSHolding(s) in Company
23rd Feb 202311:00 amRNSHolding(s) in Company
15th Feb 20234:15 pmRNSDirector/PDMR Shareholding
10th Feb 20232:19 pmBUSStatement re Directorate Changes and Board Committee Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.